We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+4.64%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$26.1B
AUM Growth
+$1.03B
(+4.1%)
Cap. Flow
-$146M
Cap. Flow
% of AUM
-0.56%
Top 10 Holdings %
Top 10 Hldgs %
13.61%
Holding
1,470
New
112
Increased
493
Reduced
531
Closed
130
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TE Connectivity
TEL
|
+$94.2M |
| 2 |
Medtronic
MDT
|
+$83.5M |
| 3 |
Verizon
VZ
|
+$54.1M |
| 4 |
Adobe
ADBE
|
+$54.1M |
| 5 |
Amazon
AMZN
|
+$50.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$81.3M |
| 2 |
Sensata Technologies
ST
|
+$78M |
| 3 |
PG&E
PCG
|
+$52M |
| 4 |
Amgen
AMGN
|
+$43.5M |
| 5 |
Lowe's Companies
LOW
|
+$40.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.67% |
| 2 | Healthcare | 15.83% |
| 3 | Consumer Discretionary | 11.21% |
| 4 | Financials | 11.2% |
| 5 | Industrials | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Qiagen
QGEN
$8.84B
| $15M | 0.06% |
392,454
+13,666
| +4% | +$503K |
|
327
Unum
UNM
$14.9B
| $14.9M | 0.06% |
402,825
+134,825
| +50% | +$5.62M |
|
|
MRSH
328
Marsh
MRSH
$86.3B
| $14.7M | 0.06% |
179,304
+54,240
| +43% | +$4.43M |
|
329
Agios Pharmaceuticals
AGIO
$1.93B
| $14.6M | 0.06% |
173,616
+2,209
| +1% | +$193K |
|
330
Equinix
EQIX
$99B
| $14.6M | 0.06% |
33,888
+6,441
| +23% | +$2.6M |
|
331
Globant
GLOB
$1.72B
| $14.5M | 0.06% |
254,649
+60,469
| +31% | +$3.02M |
|
332
Keurig Dr Pepper
KDP
$42.6B
| $14.4M | 0.06% |
117,767
-92,973
| -44% | -$11.2M |
|
333
Abbott
ABT
$176B
| $14.4M | 0.06% |
235,525
-38,000
| -14% | -$2.3M |
|
|
DNB
334
DELISTED
Dun & Bradstreet
DNB
| $14.3M | 0.05% |
116,500
-55,063
| -32% | -$6.7M |
|
335
Q2 Holdings
QTWO
$3.77B
| $14.3M | 0.05% |
250,087
+110,241
| +79% | +$6.01M |
|
336
Douglas Emmett
DEI
$1.76B
| $14.3M | 0.05% |
355,012
+149,830
| +73% | +$5.66M |
|
337
Bristol-Myers Squibb
BMY
$130B
| $14.2M | 0.05% |
255,969
-63,547
| -20% | -$3.43M |
|
338
Copa Holdings
CPA
$5.13B
| $14.2M | 0.05% |
149,702
+1,162
| +0.8% | +$130K |
|
339
Yum China
YUMC
$14.3B
| $14.2M | 0.05% |
368,296
-24,372
| -6% | -$965K |
|
340
Consolidated Edison
ED
$39.2B
| $14.1M | 0.05% |
180,482
+34,727
| +24% | +$2.65M |
|
341
FIVE9
FIVN
$2.41B
| $14.1M | 0.05% |
406,936
+62,316
| +18% | +$2.02M |
|
342
Paychex
PAYX
$42.1B
| $14M | 0.05% |
205,451
-803
| -0.4% | -$51.8K |
|
343
Oshkosh
OSK
$8.83B
| $14M | 0.05% |
198,900
+186,900
| +1,558% | +$14M |
|
|
TFCFA
344
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $14M | 0.05% |
281,161
-488
| -0.2% | -$19.3K |
|
|
VRNT
345
DELISTED
Verint Systems
VRNT
| $13.9M | 0.05% |
614,955
+263
| +0% | +$5.72K |
|
346
Avery Dennison
AVY
$13B
| $13.9M | 0.05% |
136,074
-99,868
| -42% | -$10.6M |
|
|
RHT
347
DELISTED
Red Hat Inc
RHT
| $13.9M | 0.05% |
103,150
-4,727
| -4% | -$763K |
|
348
Robert Half
RHI
$3.86B
| $13.8M | 0.05% |
212,151
-206,101
| -49% | -$13.1M |
|
349
HCA Healthcare
HCA
$91.9B
| $13.7M | 0.05% |
133,491
-909
| -0.7% | -$92K |
|
350
M&T Bank
MTB
$34.2B
| $13.6M | 0.05% |
80,202
-1,474
| -2% | -$264K |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q2 2018 Portfolio in Review
As of Q2 2018, Axa held 1,470 positions worth $26.1B, up 4.1% from $25.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Axa's Q2 2018 filing shows 112 new, 493 increased, 531 reduced and 130 closed positions. Its largest new stake was Foot Locker: 289,100 shares worth $15.2M. The largest sale was AbbVie, an estimated $81.3M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Axa's largest Q2 2018 buy was Foot Locker: 289,100 shares worth $15.2M.
- Axa added most to TE Connectivity in Q2 2018, an estimated $94.2M increase.
- Axa's biggest Q2 2018 reduction was AbbVie, cutting an estimated $81.3M.
- Axa fully exited PG&E in Q2 2018, selling an estimated $52M.
- Axa's ten largest holdings make up 14% of its $26.1B portfolio in Q2 2018.
- Axa opened 112 new positions and closed 130 in Q2 2018.
- Axa's portfolio value rose 4.1% quarter-over-quarter to $26.1B.
Based on Axa's 13F filing for Q2 2018, filed 13 Aug 2018.